Shanghai Labway Clinical Laboratory Balance Sheet Health
Financial Health criteria checks 4/6
Shanghai Labway Clinical Laboratory has a total shareholder equity of CN¥1.9B and total debt of CN¥291.9M, which brings its debt-to-equity ratio to 15.3%. Its total assets and total liabilities are CN¥2.7B and CN¥756.4M respectively.
Key information
15.3%
Debt to equity ratio
CN¥291.87m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥684.82m |
| Equity | CN¥1.91b |
| Total liabilities | CN¥756.37m |
| Total assets | CN¥2.67b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301060's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥584.5M).
Long Term Liabilities: 301060's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥171.8M).
Debt to Equity History and Analysis
Debt Level: 301060 has more cash than its total debt.
Reducing Debt: 301060's debt to equity ratio has increased from 0.7% to 15.3% over the past 5 years.
Debt Coverage: 301060's debt is well covered by operating cash flow (90%).
Interest Coverage: Insufficient data to determine if 301060's interest payments on its debt are well covered by EBIT.